Five Fallen Biotech Stocks We’re Watching for Rebounds We think opportunities abound in the sector. 2 MIN READ 04.29.2022
BioXcel Therapeutics Inks $260 Million Strategic Financing With Oaktree and Qatar Investment Authority The financing will support the commercialization of BioXcel's recently approved Igalmi sublingual film for agitation associated with schizophrenia or bipolar I or II disorder. 4 MIN READ 04.20.2022